Beijing Centergate Technologies Holding Co Ltd (000931) - Total Liabilities
Based on the latest financial reports, Beijing Centergate Technologies Holding Co Ltd (000931) has total liabilities worth CN¥1.95 Billion CNY (≈ $285.29 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Beijing Centergate Technologies Holding Co Ltd - Total Liabilities Trend (1996–2024)
This chart illustrates how Beijing Centergate Technologies Holding Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Beijing Centergate Technologies Holding 's working capital to evaluate short-term liquidity relative to the company's equity base.
Beijing Centergate Technologies Holding Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beijing Centergate Technologies Holding Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hunan Haili Chemical Co Ltd
SHG:600731
|
China | CN¥1.15 Billion |
|
KG Mobility Corp.
KO:003620
|
Korea | ₩2.07 Trillion |
|
WinMate Communication INC
TW:3416
|
Taiwan | NT$1.45 Billion |
|
Covenant Logistics Group, Inc.
NASDAQ:CVLG
|
USA | $601.89 Million |
|
Hap Seng Plantations Holdings Bhd
KLSE:5138
|
Malaysia | RM482.86 Million |
|
WideOpenWest Inc
NYSE:WOW
|
USA | $1.36 Billion |
|
Yingkou Fengguang Advanced Material Co.Ltd.
SHE:301100
|
China | CN¥327.78 Million |
|
Evolus Inc
NASDAQ:EOLS
|
USA | $249.43 Million |
Liability Composition Analysis (1996–2024)
This chart breaks down Beijing Centergate Technologies Holding Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Beijing Centergate Technologies Holding worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Centergate Technologies Holding Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Centergate Technologies Holding Co Ltd (1996–2024)
The table below shows the annual total liabilities of Beijing Centergate Technologies Holding Co Ltd from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.91 Billion ≈ $278.77 Million |
-6.68% |
| 2023-12-31 | CN¥2.04 Billion ≈ $298.74 Million |
+9.15% |
| 2022-12-31 | CN¥1.87 Billion ≈ $273.70 Million |
-0.71% |
| 2021-12-31 | CN¥1.88 Billion ≈ $275.65 Million |
+21.98% |
| 2020-12-31 | CN¥1.54 Billion ≈ $225.97 Million |
-10.48% |
| 2019-12-31 | CN¥1.73 Billion ≈ $252.44 Million |
+5.55% |
| 2018-12-31 | CN¥1.63 Billion ≈ $239.17 Million |
-12.05% |
| 2017-12-31 | CN¥1.86 Billion ≈ $271.95 Million |
-10.66% |
| 2016-12-31 | CN¥2.08 Billion ≈ $304.39 Million |
+9.56% |
| 2015-12-31 | CN¥1.90 Billion ≈ $277.82 Million |
+4.18% |
| 2014-12-31 | CN¥1.82 Billion ≈ $266.68 Million |
-50.88% |
| 2013-12-31 | CN¥3.71 Billion ≈ $542.90 Million |
+10.21% |
| 2012-12-31 | CN¥3.37 Billion ≈ $492.61 Million |
-4.93% |
| 2011-12-31 | CN¥3.54 Billion ≈ $518.13 Million |
+12.91% |
| 2010-12-31 | CN¥3.14 Billion ≈ $458.87 Million |
+6.31% |
| 2009-12-31 | CN¥2.95 Billion ≈ $431.64 Million |
-8.31% |
| 2008-12-31 | CN¥3.22 Billion ≈ $470.77 Million |
-15.27% |
| 2007-12-31 | CN¥3.80 Billion ≈ $555.61 Million |
+0.14% |
| 2006-12-31 | CN¥3.79 Billion ≈ $554.83 Million |
-9.31% |
| 2005-12-31 | CN¥4.18 Billion ≈ $611.78 Million |
-7.70% |
| 2004-12-31 | CN¥4.53 Billion ≈ $662.82 Million |
-25.74% |
| 2003-12-31 | CN¥6.10 Billion ≈ $892.59 Million |
+13.63% |
| 2002-12-31 | CN¥5.37 Billion ≈ $785.53 Million |
-27.27% |
| 2001-12-31 | CN¥7.38 Billion ≈ $1.08 Billion |
+64.92% |
| 2000-12-31 | CN¥4.48 Billion ≈ $654.86 Million |
+198.99% |
| 1999-12-31 | CN¥1.50 Billion ≈ $219.02 Million |
+67.38% |
| 1998-12-31 | CN¥894.21 Million ≈ $130.85 Million |
-14.95% |
| 1997-12-31 | CN¥1.05 Billion ≈ $153.86 Million |
+4.39% |
| 1996-12-31 | CN¥1.01 Billion ≈ $147.38 Million |
-- |
About Beijing Centergate Technologies Holding Co Ltd
Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of … Read more